Diagnostic and Management of Hand Infection.
NCT06630988 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1400
Last updated 2024-10-08
Summary
Primary or secondary (post-traumatic infections, notably related to bites, wounds, etc.) infections of the hand are very common situations, even if the epidemiology is poorly understood. For example, hand bite injuries represent 1.2 million referrals to the healthcare system per year in the United States. Their nosological framework extends from simple infections of the skin and soft tissues such as whitlows, to potentially severe deep damage such as arthritis and osteitis, or phlegmons of the tendon sheaths. The diagnostic approach is not consensual, and the contribution of additional biological parameters (inflammatory syndrome) and morphological investigations (x-rays, ultrasound, CT-scan or MRI) is not codified. Microbiology seems dominated by Staphylococcus aureus, but few studies have precisely described the microbial etiology. Consequently, probabilistic antibiotic therapy and the need to take bacteriological samples for secondary adaptation are not standardized. Likewise, surgical strategies (abstention, systematic washing or depending on evolution) remain operator dependent. We consequently aim to described diagnostic, management and related outcomes or hand infections in a specialized tertiary care center.
Conditions
- Hand Infections
- Including Whitlows
- Tendinous Infections
- Septic Arthritis
Interventions
- OTHER
-
Failure rates
Describe the management failure rate for hand infections, including panariasis, phlegmons and arthritis.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Principal Investigators
-
Florent Valour Pr Florent Valour, Pr · Hospices Civils de Lyon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2024-12-31
- Completion
- 2025-06-30
Countries
- France
Study Locations
More Related Trials
-
Staphylococcus Lugdunensis Prosthetic Joint Infection
NCT04409392 ·Status: COMPLETED
-
Daptomycin > 6 mg/kg/Day as Salvage Therapy in Patients With Complex Bone and Joint Infection: Cohort Study in a Regionalreference Center
NCT03209934 ·Status: COMPLETED
-
A Phase 1/2 Study to Evaluate the Safety, PK and Efficacy of TNP-2092 Administered Via IA Injection in PJI Participants
NCT06889701 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Sonographic Features of Cellulitis and Failure of Therapy
NCT01773499 ·Status: TERMINATED
-
Effect of Teledermatology on Length of Hospital Admission, Length of Stay, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic ED Setting
NCT03036358 ·Status: COMPLETED ·Phase: NA
-
Validation of Biomarkers Performance to Reduce Antibiotics overUse in newBorns With Suspected Clinical Signs of InfectionS
NCT06058819 ·Status: RECRUITING
-
Clinical Relevance of Intracellular Staphylococci in BOne and Joint Infections
NCT04625478 ·Status: COMPLETED
-
Clinical Evaluation of Daptomycin Bone Penetration
NCT01306825 ·Status: UNKNOWN
-
Impact of Pharmaceutical Interviews Regarding the Management of Adverse Effects Related to the Antibiotic Therapy Used to Treat Osteoarticular Infections During Return Home
NCT05248490 ·Status: COMPLETED ·Phase: NA
-
Pathogenicity Factors of Staphylococcus Pettenkoferi in Foot Wounds and Osteitis in Diabetic Patients
NCT06688084 ·Status: ACTIVE_NOT_RECRUITING
-
Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Staphylococcus
NCT02701608 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI
NCT04409769 ·Status: COMPLETED
-
The Effect of Dermatology and Teledermatology Consultations on Length of Hospital Admission, 30 Day Readmission Rate, and Antibiotic Use in Patients Presenting With Cellulitis vs Pseudocellulitis in an Academic Inpatient Setting
NCT03034694 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
NCT04933344 ·Status: UNKNOWN
-
Staphylococcus Haemolyticus in the Neonatal Intensive Care Unit of CHSD in 2023: Analysis and Trends
NCT07013864 ·Status: COMPLETED
-
Steady State Serum and Epithelial Lining Fluid (ELF) Antibiotics Concentrations Under Continous Infusion
NCT00435305 ·Status: TERMINATED
-
Oral-only Antibiotics for Bone and Joint Infections in Children
NCT04563325 ·Status: COMPLETED ·Phase: PHASE4
-
Antibiotic Stewardship to Prevent Early Sepsis in Preterm Infants
NCT06930911 ·Status: ACTIVE_NOT_RECRUITING
-
Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use
NCT03489330 ·Status: COMPLETED
-
Impact of Antibiotic Treatment of Group A Streptococcal Blistering Distal Dactylitis in Children
NCT02624882 ·Status: COMPLETED ·Phase: NA
-
Biofilm Formation in Staphylococcus Epidermidis Associated Implant Infections
NCT02640937 ·Status: COMPLETED
-
A Complicated Skin and Soft-tissue Infection Patient Registry
NCT00737269 ·Status: COMPLETED
-
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
NCT00426933 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Accuracy of New Diagnostic Technology to Determine Guide Rapid Antibiotic Treatment for Serious Infections
NCT02060513 ·Status: COMPLETED
-
Predictors of Oral Antibiotic Treatment Failure in Emergency Department Patients With Cellulitis
NCT02230813 ·Status: COMPLETED